Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
BACKGROUND
Neurofibromatosis type 1 (NF1) is a common single-gene disorder. A multidisciplinary approach to the management of NF1 patients is necessitated by the heterogeneity of clinical manifestations. Although multidisciplinary paediatric clinics have been well established, there is a dearth of such resources for adults with NF1. Herein we report our one-year institutional experience with a multidisciplinary adult NF1 clinic.


METHODS
A multidisciplinary team was assembled, and an NF Patient Registry Initiative questionnaire was adapted to collect patient-reported data during clinics. Multiple databases were searched to identify publications pertaining to the experience of other multidisciplinary NF1 clinics focusing on adult patients. Data on patient epidemiology and clinical staff were compared to our data.


RESULTS
A total of 77 patients were scheduled, and 68 attended the clinic, of whom 66 completed the intake questionnaire. The demographic and clinical data from this Canadian population are mostly consistent with previous reports, with some exceptions. Clinical data related to immune system involvement such as asthma, airway/breathing-related difficulties or allergies were striking in our NF1 population. Six relevant published reports of other NF1 clinics were identified. Reports from these studies pertained to periods ranging from 10 to 38 months, and the number of adults assessed ranged from 19 to 177 patients.


CONCLUSIONS
The structure of our clinic and the patient volume are comparable to those of other established centres found in the literature. Our data offer valuable cross-sectional prevalence statistics in the Canadian population. The patient-reported data concerning involvement of the immune system contribute to an emerging recognized medical concern within the NF1 population and warrant further clinical and basic investigation.
1Division of Neurosurgery,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.
Alireza
A
Mansouri
1Division of Neurosurgery,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.
Saber
S
Ghadakzadeh
6Faculty of Medicine,University of Toronto,Toronto,Ontario,Canada.
Talha
T
Maqbool
3Elizabeth Raab Neurofibromatosis Clinic,Toronto General Hospital,University Health Network,Toronto,Ontario,Canada.
Carolina
C
Barnett
1Division of Neurosurgery,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.
Karolyn
K
Au
1Division of Neurosurgery,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.
Paul
P
Kongkham
3Elizabeth Raab Neurofibromatosis Clinic,Toronto General Hospital,University Health Network,Toronto,Ontario,Canada.
Vera
V
Bril
1Division of Neurosurgery,Toronto Western Hospital,University Health Network,Toronto,Ontario,Canada.
Zadeh
Z
Gelareh
D000293:Adolescent; D000328:Adult; D000368:Aged; D000554:Ambulatory Care Facilities / Q000706:statistics & numerical data*; D002170:Canada; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009456:Neurofibromatosis 1 / Q000453:epidemiology* / Q000628:therapy*; D015995:Prevalence; D011795:Surveys and Questionnaires; D055815:Young Adult
Adult; NF1; clinic; multidisciplinary; neurofibromatosis